Fidson Healthcare Plc on Monday published its Fourth Quarter report for the year ended 31 December 2020.
The pharmaceutical giant reported a turnover of N18.276 billion, up by 29.97% from N14.062 billion reported in 2019.
Profit after tax for the 12 months period was N1.18 billion, up by 190.18% from N407 million profit reported in 2019.
Earnings per share (EPS) of the firm increased to N0.57 from the EPS of N0.20 in 2019, which translates to 190.18% growth year on year.
At the share price of N6.15, the P.E ratio of Fidson stands at 10.86x with earnings yield of 9.21%.